BRICS Coronary and Peripheral Stents Market Outlook (2022-2033)

The BRICS coronary and peripheral stents market size is expected to reach US$ 4,279.2 million by 2033 from US$ 1,744.1 million in 2024. The market is estimated to record a CAGR of 10.5% from 2025 to 2033.

Executive Summary and BRIC Coronary and Peripheral Stents Market Analysis:

The BRICS coronary and peripheral stents market represents a complex and high-impact segment of the global cardiovascular devices landscape, with China emerging as the dominant contributor. The region is characterized by a large and diverse patient population, rapid urbanization, and a growing emphasis on early diagnosis and interventional treatment of vascular diseases. In China, strong government focus on cardiovascular disease management and hospital modernization has significantly expanded access to catheter-based interventions. Domestic manufacturing capabilities and regulatory support for locally produced devices further strengthen market momentum. However, the market faces restraints related to centralized procurement policies and aggressive price controls, which influence product mix and limit rapid uptake of premium imported stents. Despite these pressures, continuous improvements in clinical training, procedural standardization, and infrastructure expansion support sustained demand. China’s scale, policy-driven healthcare reforms, and manufacturing depth position it as the anchor market within the BRICS stents landscape.

BRICS Coronary and Peripheral Stents Market Segmentation Analysis

Key segments that contributed to the derivation of the coronary and peripheral stents market analysis are product type, material type, application and end user.

• By product type, the coronary and peripheral stents market is segmented into bare-metal stents, drug-eluting stents, bioresorbable vascular scaffolds, and others. The drug-eluting stents segment dominated the market in 2024. Superior efficacy in reducing restenosis, longer-term patient outcomes, and widespread physician preference drove adoption, making them the most trusted choice compared to bare-metal or bioresorbable alternatives.
• By material type, the coronary and peripheral stents market is segmented into metal, polymer, and hybrid. The metal segment dominated the market in 2024. High durability, proven biocompatibility, cost-effectiveness, and established clinical success ensured dominance, as polymer and hybrid options remain limited in availability, scalability, and long-term performance validation.
• By application, the coronary and peripheral stents market is segmented into coronary artery disease and peripheral artery disease. The coronary artery disease segment dominated the market in 2024. Higher global prevalence, significant clinical burden, and greater demand for interventional procedures positioned coronary stents as the leading application, overshadowing peripheral artery disease interventions in overall market share.
• By end user, the market is segmented into hospitals, ambulatory surgical centers, cardiac catheterization labs, and specialty clinics. The hospitals segment held the largest share of the market in 2024. Comprehensive infrastructure, advanced catheterization facilities, skilled specialists, and ability to handle complex cases ensured hospitals remained the primary setting for stent implantation, surpassing smaller clinics and ambulatory centers.

BRIC Coronary and Peripheral Stents Market Outlook

The BRICS coronary and peripheral stents market is characterized by high procedural volumes and increasing standardization of interventional cardiology practices, particularly in China. Coronary stents account for the majority of interventions, while peripheral stents are gaining traction for complex arterial disease and limb-preservation procedures. A key driver is China’s rapid expansion of catheterization laboratory capacity within public hospitals, supported by national healthcare reform initiatives. Improved access to diagnostic angiography and interventional treatment has shifted care pathways away from conservative management toward earlier procedural intervention. Additionally, the strong presence of domestic stent manufacturers has improved device availability and reduced dependence on imports, supporting wider adoption across secondary and tertiary hospitals. This combination of infrastructure expansion and local manufacturing efficiency continues to reinforce China’s leadership and sustains growth across the broader BRICS market.

BRIC Coronary and Peripheral Stents Market Country Insights

Based on country, the BRIC coronary and peripheral stents market is further segmented into Russia, Brazil, South Africa, India, China, Egypt, Indonesia, Saudi Arabia, and the UAE. China held the largest share in 2024.

China dominates the BRICS coronary and peripheral stents market due to its expansive healthcare system, large patient base, and advanced domestic medical device industry. Public hospitals in urban and semi-urban areas perform high volumes of coronary interventions, with drug-eluting stents widely adopted as standard practice. Peripheral stent usage is increasing, particularly for lower-extremity arterial disease associated with diabetes and aging populations. China’s centralized procurement framework favors cost-effective, high-volume stent platforms, benefiting domestic manufacturers with strong regulatory approvals. At the same time, continuous physician training and adoption of standardized clinical guidelines are improving procedural quality nationwide. Although pricing pressures challenge supplier margins, they also enable broader patient access. Overall, China’s integration of policy support, manufacturing strength, and clinical scale firmly establishes it as the dominant force in the BRICS stents market.

BRICS Coronary and Peripheral Stents Market Company Profiles

Medtronic, Boston Scientific Corporation, Abbott, B. Braun SE, TERUMO CORPORATION, Teleflex Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Cook Medical, Meril Life Sciences and Translumina are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.

BRIC Coronary and Peripheral Stents Market Research Methodology:

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

• Primary Research

Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:

• Refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

BRICS Coronary and Peripheral Stents Key Sources Referred:

• The World Bank
• World Health Organization (WHO)
• Center for Disease Control and Prevention (CDC)
• European Society of Cardiology
• American College of Cardiology
• American Heart Association
• Asian Pacific Society of Interventional Cardiology
• Company website
• Company annual reports
• Company investor presentations